Joint Replacement Consumer Awareness Campaign Endorsed by Prominent Orthopaedic... ( Leading join...)

Joint Replacement Consumer Awareness Campaign Endorsed by Prominent Orthopaedic Scientist

Date:5/24/2009

Leading joint replacement scientist says the BoneSmart.org consumer awareness campaign extends the mission statement of surgeons and adds great valuable to prospective joint patients.

(PRWEB) May 24, 2009 -- Dr. Ian Clarke, medical researcher and founder of the Peterson Tribology Laboratory at Loma Linda University, has had a research career involving the wear phenomena of joint replacement bearings. He has joined the BoneSmart.org global consumer awareness campaign to help improve access to information for candidates for hip replacement and knee replacement surgery.

By providing insight into traditional and alternative materials used in modern joint replacement surgery, the BoneSmart® campaign empowers patients to learn about the options available to them for knee replacement or hip replacement surgery, and to initiate informed discussions about their options with their surgeons.

In his research, Dr. Clarke studies the wear performance of hip and knee joints using special joint-simulation machines. The materials he studies are at the cutting edge of today's technology, including the latest polyethylene, ceramic and metal alloys for hip and knee joints. The results of his studies provide surgeons and patients alike with information that they can use to choose the right materials.

He believes that timely information about current issues and latest technologies is essential to joint replacement consumers, and that the BoneSmart® campaign helps achieve this aim. The Bonesmart website is continually updated and has easily accessible information on its website - including a moderated, online forum for j
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. MIT is pleased to announce that it has signed the Joint Venture agreement with its Chinese partners and has received an initial order of 120 units for Animal vaccination
2. Winner Medical Establishes Joint Venture With West China Hospital in Chengdu, China
3. Joint Statement from AHCA, NCAL, and the Alliance on the Obama Administrations FY 2010 Budget
4. Bausch & Lomb and 20/10 Perfect Vision Finalize Refractive Surgery Joint Venture
5. Dr. Michael B. Cates Takes Leadership Role on AVMAs One Health Joint Steering Committee
6. Joint Commission Awards TeamHealth Teleradiology Second Consecutive Gold Seal of Approval(TM)
7. Specialists On Call Renews Joint Commission Accreditation
8. Female hormone cycle affects knee joints
9. Coalition to Salute Americas Heroes(TM) Applauds Presidents Announcement to Create Joint Virtual Lifetime Records
10. Study assesses new surgical procedure for regenerating cartilage in damaged knee joints
11. Hahnemann University Hospital Awarded Certification From the Joint Commission for Ventricular Assist Devices

Post Your Comments:

Related Image:

Joint Replacement Consumer Awareness Campaign Endorsed by Prominent Orthopaedic Scientist

(Date:5/24/2013)... General Data Company Inc., a leading ... data management products and solutions, has announced that ... of Durham, North Carolina, a leading manufacturer and ... clinical and research pathology marketplace. TBS will become ... specialty products and solutions to hospitals, independent labs ...

(Date:5/24/2013)... first conference of its kind, Impacts World 2013 ... decision makers from politics, business and civil society ... climate impact research across sectors and scales. , ... 2013 on May 27th, 1pm to 1:55pm and ... Speakers include: , Connie Hedegaard, EU ...

(Date:5/24/2013)... can healthy people who hear voices help schizophrenics? Finding the ... at the University of Bergen. , Researchers from the Bergen ... on how to help schizophrenics, who hear voices. The way ... voices, but who do not suffer from a mental illness. ... processes causing people to hear voices. A recent report published ...

(Date:5/24/2013)... May 24, 2013 The Icahn School ... International (CDI) exclusive license rights to commercially develop ... medicine applications. These cells are capable of further differentiation ... cardiomyocytes, endothelial cells, and vascular smooth muscle cells, and ... damaged heart tissue. , The original agreement announced in ...

(Date:5/24/2013)... The creative flair and design talent of graduating students ... Textiles and Clothing (ITC) have won applause from the ... 22 May at The Mira Hong Kong. ... various knitwear producers and yarn suppliers, the annual Knitwear ... from 20 graduating students majoring in knitwear design. The ...

Breaking Medicine News(10 mins):Health News:General Data Acquires Triangle Biomedical Sciences 2 Health News:General Data Acquires Triangle Biomedical Sciences 3 Health News:Help at hand for schizophrenics 2 Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 2 Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 3 Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 4 Health News:PolyU Stages Knitwear Fashion Show 2

[0] General Data Acquires Triangle Biomedical Sciences [0] Impacts conference on climate change effects [0] Help at hand for schizophrenics [0] Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles [0] PolyU Stages Knitwear Fashion Show

... from Strong International Performance and InLight ... Equipment Sales, ... personal and environmental radiation,monitoring, today reported record performance in its first fiscal ... -- Revenue reached a record $21.8 million on higher international revenues ...

... Sensitive Customer Health Care ... Data on Laptops and Desktops, ... global,leader in enterprise data protection, today announced that Payformance,Health, a ... Funds Transfer (EFT) and Electronic Remittance,Advice (ERA) services, has standardized ...

... Enables Improved Patient Safety and Office ... ... Jan. 31 Kryptiq, the leading provider,of next generation healthcare ... A four-hospital,organization with 55 physician clinics in the Springfield, MO ...

... 31 Oncology focused,biopharmaceutical product development company ... finalized its Rhitol(TM) Phase II clinical trial,with ... treatment cycle. Rhitol(TM),is evaluated as treatment for ... (GvHD) intolerant or resistant to standard immunosuppressive,treatment., ...

... ... -- Revises 2008 EPS Guidance Primarily to Reflect the Sale of Medical ... Imaging, -- Reaffirms Expected Non-GAAP EPS CAGR of at ... Through 2010, Subject to Certain Assumptions, -- Completes Sale of Medical Imaging Business, Reports as Discontinued, ...

... 31, 2008 The Procter &,Gamble Company (NYSE: ... to,$21.6 billion for the quarter. Sales were up behind ... and double-digit organic,growth in developing regions. Organic volume increased ... the quarter. Diluted earnings per,share increased 17 percent to ...

Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results Health Care Solutions Provider Payformance Health Standardizes on PGP Encryption for Data Security CoxHealth Deploys Kryptiq ePrescribing Solution Kiadis Pharma Announces Successful Completion of Rhitol(TM) Phase II Clinical Study Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company

(Date:5/23/2013)... TARRYTOWN, N.Y. , May 23, 2013 /PRNewswire/ ... reconstruction following mastectomy is an appropriate option ... mutations seeking to surgically reduce their breast cancer ... involves a gradual expansion process and a second ... of implants in the same surgery as mastectomy ...

(Date:5/23/2013)... -- BioElectronics Corporation (OTC Pink: BIEL), the maker of very ... panel meeting for non-thermal shortwave diathermy: The ... Meeting was held on May 21, 2013 in ... the meeting was very narrow, in that the FDA ... application of non-thermal shortwave diathermy for the treatment of ...

(Date:5/23/2013)... , May 23, 2013 Datameer announced today ... enable data discovery on their big data platform. ... tools they need to quickly and easily visualize ... A Fortune 19 company, Cardinal Health is ... It provides pharmaceuticals and medical products to more ...

Breaking Medicine Technology:Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2 Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3 BioElectronics and Pulsed Shortwave Therapy Make Progress 2 Cardinal Health Selects Datameer for Healthcare Data Discovery 2

[0] Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results [0] BioElectronics and Pulsed Shortwave Therapy Make Progress [0] Cardinal Health Selects Datameer for Healthcare Data Discovery

... , , , ... AMGN ) today announced positive top-line results from a pivotal ... acid) administered as an intravenous (IV) infusion in the treatment of ... including breast and prostate cancer) or multiple myeloma. , ...

... , , , , ... Institute (KLRI) has published two new publications on hormone therapies and ... adults. , , Cardiovascular disease caused by atherosclerosis, ... greatest single killer of American women--40% of total deaths--and the rate ...

Cached Medicine Technology:Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 2 Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 3 Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 4 Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 5 Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 6 Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 7 Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 8 TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men 2 TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men 3

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men

Straight shafts with fine pierse type tips. Flat open serrated handle with dull finish....

Straight shafts with micro Pierse type tips. Flat open serrated handle, dull finish....

Micro pierse type tips with 2 mm angled Colibri style jaws. Flat open serrated handle, dull finish....

5 mm jaws with teeth provide secure fixation of occular structures....

Medicine Products:

Pierse Type Fine Skeleton Forceps Pierse Type Micro Skeleton Forceps Pierse Type Colibri Forceps Green Straight Fixation Forceps